Drug recall · August 9, 2023
Cromolyn Sodium Oral Solution recall
Why: CGMP deviation: product released prior to supplier approval.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96.
- Lots / codes
Lot: 23CE2, Exp. 03/31/2026
- Quantity
- 44 cartons
- Company
- The Ritedose Corporation, Columbia, SC
- Distribution
- Nationwide in the US
- Initiated
- July 21, 2023 · Voluntary: Firm initiated
- Classified
- July 31, 2023
- Reported
- August 9, 2023
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cromolyn
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.